Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study

Table 3 The Linear regression analysis of PSM cohort

Variable	B	SE	Beta	t	P	95%CI	VIF
ARNI	0.036	0.05	0.048	0.715	0.475	-0.062–0.134	1.432
Age	-0.01	0.003	-0.223	-3.308	0.001	-0.015–0.004	1.443
Sex
Male	Ref
Female	0.068	0.049	0.085	1.377	0.169	-0.029–0.165	1.211
Hypertension
Yes	0.013	0.043	0.017	0.298	0.766	-0.072–0.097	1.049
No	Ref
Diabetes
Yes	0.013	0.043	0.017	0.298	0.766	-0.158–0.028	1.049
No	Ref
Smoking history
No smoking	Ref
Quit smoking	0.015	0.059	0.016	0.252	0.801	-0.102–0.132	1.222
Still smoking	0.02	0.052	0.026	0.393	0.695	-0.081–0.122	1.343
Drinking history
No drinking	Ref
Quit drinking	0.053	0.088	0.035	0.602	0.548	-0.12–0.225	1.098
Still drinking	0.034	0.044	0.046	0.783	0.434	-0.052–0.121	1.112
NT-proBNP	< -0.001	0	-0.055	-0.942	0.347	0	1.084
CTNI	< -0.001	0	-0.039	-0.686	0.493	0	1.048
β Receptor blocker
Yes	-0.008	0.083	-0.006	-0.1	0.92	-0.173–0.156	1.043
No	Ref
Spironolactone
Yes	-0.055	0.05	-0.063	-1.094	0.275	-0.154–0.044	1.063
No	Ref
Statins
Yes	0.034	0.119	0.016	0.284	0.776	-0.201–0.269	1.055
No	Ref

ISSN: 1471-2261